Chang David D — SEC Form 4 filings
SEC reporting owner CIK 1611024. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-18.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-31 to 2026-03-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 235,703 shares, $458,213 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 95,269 shares @ $1.80 ($171,484) in Allogene Therapeutics, Inc., filed 2026-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | President and CEO, Director | 7 | — | 4 legs · 235,703 sh · $458,213 | 6 |
Form 4 filings — Chang David D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-18 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 47,763 @ $2.47 | EDGAR |
| 2026-02-04 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 95,269 @ $1.80 · Grant/award (A): 1,387,931 (derivative) @ $0 · Grant/award (A): 392,586 (derivative) @ $0 | EDGAR |
| 2025-03-18 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 46,668 @ $1.96 | EDGAR |
| 2025-02-05 | 4 | Allogene Therapeutics, Inc. (ALLO) | Sale (S): 46,003 @ $1.68 | EDGAR |
| 2024-05-20 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 344,828 @ $2.90 | EDGAR |
| 2024-03-18 | 4 | Allogene Therapeutics, Inc. (ALLO) | Tax withholding (F): 53,393 @ $4.33 | EDGAR |
| 2024-01-31 | 4 | Allogene Therapeutics, Inc. (ALLO) | Grant/award (A): 317,800 @ $0 · Grant/award (A): 1,123,535 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1611024 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →